Tremey Benjamin, Tazarourte Karim, Ract Catherine, Gabteni Mahjoub, Lavagna Leila, Dépret-Vassal Jacqueline, Ségalin Valérie, Saintonge Stéphane, Vigué Bernard
Department of Anesthesiology, Hôpital Foch, 40 rue Worth, 92151 Suresnes, France.
Intensive Care Med. 2009 Aug;35(8):1444-8. doi: 10.1007/s00134-009-1465-9. Epub 2009 Apr 4.
To assess compliance and impact of a teaching program on guidelines for the management of severe bleeding under oral anticoagulation therapy in emergency departments (EDs).
Multicenter, before-after observational studies in six French EDs.
Forty-five patients in 2003 and 54 patients in 2005 consecutively admitted with severe bleeding under oral anticoagulation therapy.
A specific teaching program on management of severe bleeding under oral anticoagulation therapy, performed by an expert physician.
Primary end-point was the use of prothrombin complex concentrate-vitamin K association between the two study periods. Nine patients (20%) in 2003 and 29 patients (54%) in 2005 received this association (P < 0.01). Almost one-third of patients had only withholding oral anticoagulation therapy. Adverse events and mortality rate did not differ between the two phases.
Compliance with guidelines on the management of severe bleeding under oral anticoagulation remains poor and might be improved by specific teaching program.
评估一项教学计划对急诊科口服抗凝治疗严重出血管理指南的依从性及影响。
在法国六个急诊科开展的多中心前后对照观察性研究。
2003年连续收治45例口服抗凝治疗下发生严重出血的患者,2005年连续收治54例。
由一名专家医师开展关于口服抗凝治疗严重出血管理的特定教学计划。
主要终点是两个研究阶段之间凝血酶原复合物浓缩剂 - 维生素K联合使用情况。2003年有9例患者(20%),2005年有29例患者(54%)接受了这种联合治疗(P < 0.01)。近三分之一的患者仅停用了口服抗凝治疗。两个阶段的不良事件和死亡率无差异。
口服抗凝治疗严重出血管理指南的依从性仍然较差,特定教学计划可能会改善这种情况。